We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Spectral Imaging Visually Discriminates Different Microbes

By LabMedica International staff writers
Posted on 01 Mar 2011
A novel microscopic method is able to differentiate between many diverse microbes in a single field of view. More...


The technique, known as combinatorial labeling and spectral imaging fluorescent in situ hybridization (CLASI-FISH), is faster than traditional ways of identifying the microbes in a sample.

Scientists at the Marine Biological Laboratory (MBL; Woods Hole MA, USA) used the CLASI-FISH method to reveal the spatial structure of the community of microbes in an oral biofilm. They demonstrated a fluorescence-imaging assay capable of distinguishing 28 differently labeled microbes in a single field of view, significantly improving the number of fluorescent labels previously distinguished in microbial fluorescent in situ hybridization (FISH). Their 15-taxon mixture of laboratory-grown oral microbes consisted of cells of varying complexity in their cell wall composition and represented both Gram-positive and Gram-negative organisms.

Cells of the genera Streptococcus and Prevotella were the most abundant, whereas cells of the genera Veillonella, Prevotella, and Actinomyces showed the most interspecies associations including those with Streptococcus, Rothia, Gemella, Pasteurellaceae, Porphyromonas, and Neisseriaceae. In addition, Actinomyces and Prevotella were found to have significant association frequencies with Fusobacterium.

Gary Borisy, PhD, president and director of the MBL, commenting on the method said, "We get information on the presence of many different microbes at once and get it quickly, cheaply, and perhaps more accurately than other methods. It is very possible that this technology will enable a new kind of clinical diagnostic procedure, so that it will be possible to very quickly and accurately diagnose a specimen for many kinds of microbes at once. As an alternative to culturing, it could be faster, cheaper, and better." The study was published online on February 16, 2011, in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Related Links:
Marine Biological Laboratory



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.